<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
(Check One): (X) Form 10-K (__) Form 20-F (__) Form 11-K
(__) Form 10-QSB (__) Form N-SAR
For Period Ended: 09/30/97
[__] Transition Reports on Form 10-K
[__] Transition Reports on Form 20-F
[__] Transition Reports on Form 11-K
[__] Transition Reports on Form 10-Q
[__] Transition Reports on Form N-SAR
For the Transition Period Ended:___________________________________
___________________________________________________________________
Read Instructions (on back page) Before Preparing Form.
Please Print or Type.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION
HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.
___________________________________________________________________
If the notification relates to a portion of the filing checked
above, identify the item(s) to which the notification relates:
___________________________________________________________________
PART I - REGISTRANT INFORMATION
___________________________________________________________________
Full Name of Registrant:
Alliance Health, Inc.
Former Name if Applicable
___________________________________________________________________
Address of Principal Executive Office (Street and Number)
421 E. Airport Freeway
City, State and Zip Code
Irving, TX 75062
PART II--RULES 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if applicable)
(a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without
unreasonable effort or expense;
(b) The subject annual report, semi-annual report,
transition report on Form 10-K, Form 20-F, Form 11-K,
Form N-SAR, or portion thereof, will be filed on or
before the fifteenth calendar day following the pres-
[X] cribed due date; or the subject quarterly report or
transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following
the prescribed due date; and
(c) The accountant's statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed
within the prescribed time period.
The auditors for Alliance Health, Inc. have been unable to obtain the
necessary information to meet the filing requirements of Form 10-KSB, both
as to form and timeliness, due to the typical delays caused by the
Thanksgiving and Christmas holidays, and will not have sufficient time to
complete their examination by the required filing date.
PART IV--OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to
this notification.
Sharilyn J. Bruntz Wilson 972 255-5533
____________________________ __________ _________________
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30 of
the Investment Company Act of 1940 during the preceding 12
months (or for such shorter period that the registrant was
required to file such reports) been filed?
If the answer is no, identify report(s): [X] Yes [_] No
________________________________________________________________
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be
included in the subject report or portion thereof?
[ ] Yes [X] No
________________________________________________________________
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be
made.
Alliance Health, Inc.
__________________________________________________________
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: 12/24/97 By: /s/ Sharilyn J. Bruntz Wilson
Sharilyn J. Bruntz Wilson,
Vice President
INSTRUCTION: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name
and title of the person signing the form shall be typed or printed
beneath the signature. If the statement is signed on behalf of the
registrant by an authorized representative (other than an executive
officer), evidence of the representative's authority to sign on
behalf of the registrant shall be filed with the form.
ATTENTION
INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT
CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240, 12b-25) of
the General Rules and Regulations under the Securities
Exchange Act of 1934.
2. One signed original and four conformed copies of this form and
amendments thereto must be completed and filed with the
Securities and Exchange Commission, Washington, D.C., 20549,
in accordance with Rule 0-3 of the General Rules and
Regulations under the Act. The information contained in or
filed with the form will be made a matter of public record in
the Commission files.
3. A manually signed copy of the form and amendments thereto
shall be filed with each national securities exchange on which
any class of securities of the registrant is registered.
4. Amendments to the notifications must also be filed on form
12b-25 but need not restate information that has been
correctly furnished. The form shall be clearly identified as
an amended notification.
5. Electronic Filers. The form shall not be used by electronic
filers unable to timely file a report solely due to electronic
difficulties. Filers unable to submit a report within the
timer period prescribed due to difficulties in electronic
filing should comply with either Rule 201 or Rule 202 of
Regulation S-T or apply for an adjustment in filing date
pursuant to Rule 13(b) of Regulation S-T.
